FR
Therapeutic Areas
Senseonics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Eversense E3 / XL (180-day) | Continuous Glucose Monitoring for Diabetes | FDA PMA Approved |
| Eversense 365-day System | Continuous Glucose Monitoring for Diabetes | CE Mark Approved |
| Next-Generation CGM System | Continuous Glucose Monitoring for Diabetes | Research & Development |